Skip to main content

Risk Mitigation for Seniors

Delivering precision medicine to long-term and post-acute care

Our senior care experts and solutions can help reduce readmissions, ED visits, falls, and polypharmacy.
  • Adverse drug reaction Risk Assessments
  • Best-in-class 16+ specialty PGx Profile
  • Advanced molecular diagnostic testing
  • Quality improvement program tools
  • Clinical guidance and support from PGxperts and partners
Button Layout
Please enable JavaScript in your browser to complete this form.
Name
By filling out this form, you agree to receive communications like newsletters, marketing or promotional materials, and other information from AccessDx Laboratory and our parent company, Aranscia. You may opt-out of receiving communications from us by using the unsubscribe link at the bottom of all emails or contacting us directly.

Experience the benefits of precision medicine

Reduce
Readmissions

52% reduction in readmissions1

Reduce
Falls

30% lower risk of significant adverse drug events2

Reduce
Costs

$4,382 in cost savings per resident1

PGx in Long-Term Care

Genetic variation can lead to improper dosing, side effects, and interactions, especially in the long-term care setting and nearly all clinical specialties, including:

  • Anesthesiology
  • Behavioral Health
  • Cardiology
  • Dermatology
  • Endocrinology
  • Gastroenterology
  • Genitourinary
  • Hematology
  • Infectious Disease
  • Neurology
  • Oncology & Immunology
  • Ophthalmology
  • Otolaryngology
  • Pain Management
  • Rheumatology
  • Transplant

Risk Mitigation Program

We partner with communities and facilities to identify, review, and test residents at risk for drug-gene interactions, then personalize prescribing based on PGx insights. Program partners can then optimize their ongoing prescribing patterns with ongoing resident monitoring with clinical decision support tools.

  1. Swen, Jesse J., et al. The Lancet 401.10374 (2023): 347-356
  2. https://doi.org/10.1371/journal.pone.0170905